3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Myeloproliferative Disorders
3
Melanoma
3
Skin Neoplasms
2
Lung Neoplasms
2
Thrombosis
1
Pyruvate Kinase Deficiency of Red Cells
1
Precancerous Conditions
1
Pancreatic Cyst
1
Neuroendocrine Tumors
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphatic Metastasis
1
Locally Advanced Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diagnosis of Cancer of Various Organs
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Interventions
Cyclophosphamide
6
pembrolizumab
5
fludarabine phosphate
5
Vinblastine
5
Nivolumab
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Doxorubicin
5
Dacarbazine
5
fludarabine
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
pegfilgrastim
3
Etoposide
3
Cyclosporine
3
Busulfan
3
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Azacitidine
2
treosulfan
1
tocilizumab
1
thymoglobulin
1
tafasitamab
1
selinexor
1
polatuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Blood Specimen Collection
×
30 days
×
Clear all
No trials found.